Ebrahim Haroon, MD
-
RolePsychiatry
-
Research Program
-
Practicing Since1998
Background
Ebrahim Haroon, MD, is an attending psychiatrist at Emory Healthcare and serves as medical director of the Emory Behavioral Immunology Program. Dr. Harron is an associate professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine.
Titles & Roles
-
Associate Professor, Department of Psychiatry and Behavioral SciencesEmory University School of Medicine
-
Medical Director, Emory Behavioral Immunology ProgramEmory University
Education & Training
Education
- Residency, Psychiatry, 1998Yale Psychiatric Institute
- Internship, Psychiatry, 1995Tufts - New England Medical Center
- Medical Education, MBBS, 1981Madurai Medical College
Board Certifications
- PsychiatryAmerican Board of Psychiatry and Neurology, 2000
Professional Memberships
Dr. Haroon is a member of several institutional and national committees including the Cancer Prevention Control Research Program at Winship Cancer Institute of Emory University, Emory Institutional Review Board and the Awards Committee of Society for Biological Psychiatry.
Research
Dr. Haroon's research interests are in identifying early pathophysiological changes associated with depression secondary to psychosocial and medical disorders.
Publications
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
The new normal: neural network adaptations in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
E Haroon, AH Miller | 06/20/2025 |
|
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
DR Goldsmith, CS Ning, GP Strauss, RE Gross, JA Cooper, EC Wommack, E Haroon, JC Felger, EF Walker, MT Treadway, AH Miller | 04/24/2025 |
|
Not All Neuroinflammation Is Created Equal: The Dual Nature of Astrogliosis. Biological psychiatry |
E Haroon, JC Felger, AH Miller | 04/15/2025 |
|
Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder. Biological psychiatry |
AH Miller, JC Felger, E Haroon | 04/10/2025 |
|
Molecular psychiatry |
MT Treadway, SM Etuk, JA Cooper, S Hossein, E Hahn, SA Betters, S Liu, AR Arulpragasam, BAM DeVries, N Irfan, MR Nuutinen, EC Wommack, BJ Woolwine, M Bekhbat, PA Kragel, JC Felger, E Haroon, AH Miller | 04/01/2025 |
|
Comprehensive psychoneuroendocrinology |
A Singh, M Bekhbat, DR Goldsmith, NA Le, EC Wommack, Z Li, E Haroon, JC Felger | 02/01/2025 |
|
Rewiring the brain: Inflammation's impact on glutamate and neural networks in depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
E Haroon, AH Miller | 11/01/2024 |
|
Research square |
M Treadway, S Etuk, J Cooper, S Hossein, E Hahn, S Betters, S Liu, A Arulpragasam, B DeVries, N Irfan, M Nuutinen, E Wommack, B Woolwine, M Bekhbat, P Kragel, J Felger, E Haroon, A Miller | 03/05/2024 |
|
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry |
JJ Rakofsky, HA Stoddard, E Haroon, AP Hermida, SM Debrey, AL Crowell, BW Dunlop | 12/01/2023 |
|
Magnetic resonance imaging |
A Joy, R Nagarajan, ES Daar, J Paul, A Saucedo, SK Yadav, M Guerrero, E Haroon, P Macey, MA Thomas | 01/01/2023 |
Showing 1 to 10 of 61 entries
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.9 |
| Provider showed concern |
| 4.9 |
| Provider explained things clearly |
| 4.9 |
| Provider discussed treatment options |
| 4.9 |
| Provider included you in decisions |
| 4.9 |
| Likelihood of recommending this provider |
|
04/09/2025 |
Care provider provided me answers clearly. |
|
03/19/2025 |
Very good |
|
02/18/2025 |
Great customer service |
|
02/14/2025 |
Dr. Haroon is the most genuine, kind and brilliant doctor I could imagine. He listens without judgment and draws on his vast experience to offer valuable guidance and support. He has helped me successfully address short-term concerns and long-term treatment goals, and I feel so lucky to have him in my life. |
|
12/26/2024 |
Dr. Haroon is fantasic. I truly appreciate his detail and followup. Working with Dr. Harron has helped me mentally and through various phases of my recovery. I attribute much of my mental recovery to the work I have done with Dr. Haroon. I truly appreciate his wisdom, experience, knowledge, and caring. |
|
11/19/2024 |
Dr. Haroon listens carefully and has provided extremely good therapies. |
|
07/10/2024 |
Dr. Haroon was quite personable and exceptionally knowledgeable. I would recommend him without reservation. |
|
04/06/2024 |
Always good |
|
10/31/2023 |
Dr. Haroom was so kind, informative and easy to talk to! He is obviously a compassionate person, but also provided so many helpful insights and suggestions. |
|
10/24/2023 |
This was exceptionally good visit. Maybe because I had something to talk about this time and some thoughts about it. I felt very heard and understood and Dr Haroom described back to me what I had been thru - very good visit!!!! |
Showing 1 to 10 of 14 entries